Eli Lilly’s Mounjaro added to China’s state insurance list for diabetes treatment

Eli Lilly’s popular drug Mounjaro will be added to China’s state-run health insurance scheme from January 1 for patients with type 2 diabetes, the National Healthcare Security Administration said in a website notice on Sunday.